Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
M	O
Service:	O
MEDICINE	O
Allergies:	O
No	O
Known	O
Allergies	O
/	O
Adverse	O
Drug	O
Reactions	O
Attending:	O
___.	O
Chief	O
Complaint:	O
Blood	O
in	O
the	O
urine.	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
Hemodialysis.	O
History	O
of	O
Present	O
Illness:	O
___	O
year-old	O
male	O
with	O
ESRD	O
on	O
HD	O
(MWF),	O
known	O
history	O
of	O
bilateral	O
renal	O
masses	O
(but	O
with	O
decision	O
not	O
to	O
pursue	O
further	O
invasive	O
workup),	O
and	O
hypertension	O
who	O
presented	O
to	O
___	O
___	O
this	O
morning	O
with	O
3	O
days	O
of	O
gross	O
hematuria.	O
Patient	O
reports	O
that	O
three	O
days	O
prior,	O
he	O
noticed	O
bright	O
red,	O
bloody	O
urine.	O
He	O
went	O
to	O
see	O
his	O
urologist	O
who	O
scheduled	O
him	O
for	O
a	O
CT	O
scan	O
in	O
late	O
___.	O
He	O
continued	O
to	O
have	O
bloody	O
urine	O
the	O
next	O
two	O
days.	O
Due	O
to	O
the	O
development	O
of	O
thick	O
blood	O
(not	O
clots),	O
he	O
presented	O
to	O
___	O
where	O
CT	O
abd/pelvis	O
which	O
showed	O
bilateral	O
partial	O
exophytic	O
renal	O
masses,	O
incidental	O
pancreatic	O
lesion	O
and	O
a	O
partial	O
distended	O
bladder	O
with	O
clots.	O
The	O
OSH	O
ED	O
was	O
unable	O
to	O
pass	O
a	O
Foley	O
so	O
he	O
was	O
transferred	O
to	O
___	O
for	O
evaluation.	O
Patient	O
reports	O
some	O
dysuria	O
which	O
started	O
after	O
multiple	O
attempts	O
to	O
place	O
a	O
foley	O
catheter.	O
He	O
denies	O
fevers,	O
chills,	O
SOB,	O
chest	O
pain,	O
orthopea,	O
PND,	O
abdominal	O
pain,	O
back	O
pain,	O
hematochezia,	B-Lower_gastrointestinal_haemorrhage
melena.	B-Upper_gastrointestinal_haemorrhage
.	O
In	O
the	O
ED,	O
initial	O
VS:	O
T	O
98.2	O
HR	O
59	O
BP	O
177/44	O
O2	O
100%RA.	O
In	O
the	O
ED	O
she	O
was	O
given	O
8mg	O
morphine	O
and	O
2mg	O
dilaudid	O
during	O
placement	O
of	O
foley	O
catheter.	O
Urology	O
was	O
consulted	O
who	O
put	O
patient	O
on	O
continuous	O
bladder	O
irrigation	O
which	O
initially	O
irrigated	O
blood	O
clots	O
but	O
few	O
hours	O
after	O
irrigation	O
color	O
became	O
more	O
pink	O
and	O
clear.	O
Past	O
Medical	O
History:	O
-	O
ESRD	O
on	O
___	O
hemodialysis	O
for	O
the	O
past	O
___	O
years.	O
-	O
Diastolic	O
heart	O
failure	O
with	O
preserved	O
EF	O
-	O
Bilateral	O
renal	O
masses,	O
per	O
family	O
have	O
been	O
followed	O
serially	O
with	O
imaging	O
and	O
are	O
slow-growing	O
-	O
Hypertension	O
-	O
BPH	O
-	O
Gout	O
-	O
Hyperlipidemia	O
-	O
S/P	O
Carotid	O
Endarterectomy	O
-	O
S/P	O
cataract	B-Visual_impairment
surgery	O
-	O
S/P	O
knee	O
replacement	O
Social	O
History:	O
___	O
Family	O
History:	O
No	O
family	O
history	O
of	O
kidney	O
disease,	O
one	O
daughther	O
died	O
of	O
breast	O
cancer	O
at	O
age	O
___.	O
Physical	O
Exam:	O
VS:	O
T	O
96.5	O
BP	O
150/64	O
HR	O
67	O
O2	O
96%RA	O
GENERAL:	O
Well-appearing	O
man	O
in	O
NAD,	O
comfortable,	O
appropriate.	O
HEENT:	O
NC/AT,	O
PERRLA,	O
EOMI,	O
sclerae	O
anicteric,	O
mucous	O
memberanes	O
dry,	O
OP	O
clear.	O
NECK:	O
Supple,	O
no	O
cervical	O
or	O
supraclavicular	O
lympphadenopathy	O
LUNGS:	O
CTA	O
bilat,	O
no	O
r/rh/wh,	O
good	O
air	O
movement,	O
resp	O
unlabored.	O
HEART:	O
RRR,	O
nl	O
s1/s2,	O
___	O
systolic	O
murmur	O
radiating	O
to	O
carotids,	O
___	O
murmurs	O
at	O
mitral	O
area.	O
ABDOMEN:	O
Soft/NT/ND	O
EXTREMITIES:	O
WWP,	O
2+	O
edema.	O
SKIN:	O
No	O
rashes	O
or	O
lesions.	O
NEURO:	O
Awake,	O
A&Ox3	B-Delirium
Pertinent	O
Results:	O
___	O
11:00AM	O
BLOOD	O
WBC-8.9	O
RBC-3.47*	O
Hgb-11.6*	O
Hct-33.1*	O
MCV-95	O
MCH-33.5*	O
MCHC-35.1*	O
RDW-13.2	O
Plt	O
___	O
___	O
07:18AM	O
BLOOD	O
WBC-8.3	O
RBC-3.10*	O
Hgb-10.5*	O
Hct-29.4*	O
MCV-95	O
MCH-33.8*	O
MCHC-35.7*	O
RDW-13.4	O
Plt	O
___	O
___	O
06:04AM	O
BLOOD	O
WBC-7.8	O
RBC-3.15*	O
Hgb-10.7*	O
Hct-29.5*	O
MCV-94	O
MCH-33.8*	O
MCHC-36.1*	O
RDW-13.5	O
Plt	O
___	O
___	O
11:00AM	O
BLOOD	O
Neuts-71.9*	O
___	O
Monos-5.1	O
Eos-3.7	O
Baso-0.4	O
___	O
11:00AM	O
BLOOD	O
Glucose-120*	O
UreaN-53*	O
Creat-4.9*	O
Na-137	O
K-4.2	O
Cl-94*	O
HCO3-32	O
AnGap-15	O
___	O
07:18AM	O
BLOOD	O
Glucose-101*	O
UreaN-58*	O
Creat-4.4*	O
Na-136	O
K-3.8	O
Cl-98	O
HCO3-28	O
AnGap-14	O
___	O
06:04AM	O
BLOOD	O
Glucose-98	O
UreaN-36*	O
Creat-3.8*	O
Na-138	O
K-3.9	O
Cl-96	O
HCO3-33*	O
AnGap-13	O
___	O
07:18AM	O
BLOOD	O
Lipase-28	O
___	O
07:18AM	O
BLOOD	O
Calcium-7.9*	O
Phos-5.2*	O
Mg-1.6	O
___	O
06:04AM	O
BLOOD	O
Calcium-8.4	O
Phos-4.2	O
Mg-1.9	O
___	O
11:00AM	O
URINE	O
Color-Red	O
Appear-Cloudy	O
Sp	O
___	O
___	O
04:40PM	O
URINE	O
Color-Yellow	O
Appear-Clear	O
Sp	O
___	O
___	O
11:00AM	O
URINE	O
Blood-LG	O
Nitrite-NEG	O
Protein-300	O
Glucose-NEG	O
Ketone-NEG	O
Bilirub-NEG	O
Urobiln-NEG	O
pH-8.0	O
Leuks-LG	O
___	O
04:40PM	O
URINE	O
Blood-MOD	O
Nitrite-NEG	O
Protein-30	O
Glucose-NEG	O
Ketone-NEG	O
Bilirub-NEG	O
Urobiln-NEG	O
pH-5.0	O
Leuks-MOD	O
___	O
11:00AM	O
URINE	O
RBC->182*	O
WBC->182*	O
Bacteri-NONE	O
Yeast-NONE	O
Epi-0	O
___	O
04:40PM	O
URINE	O
RBC-30*	O
WBC-10*	O
Bacteri-FEW	O
Yeast-NONE	O
Epi-0	O
Urine	O
Culture:	O
___:	O
Final:	O
No	O
growth.	O
CT	O
Abdomen/Pelvis:	O
OSH:	O
Bilateral	O
partially	O
exophytic	O
renal	O
lesions	O
noted.	O
The	O
largest	O
and	O
most	O
irregular	O
in	O
appearance	O
projects	O
from	O
the	O
R	O
kidney	O
and	O
measures	O
up	O
to	O
approximately	O
5.4cm.	O
This	O
mass	O
is	O
heterogeneous	O
and	O
is	O
generally	O
of	O
increased	O
density,	O
likely	O
corresponding	O
to	O
the	O
patient's	O
known	O
renal	O
neoplasm.	O
Bladder	O
partially	O
distended	O
and	O
contains	O
dependent	O
clotted	O
blood	O
products.	O
Diverticulosis.	O
Incidental	O
18	O
mm	O
hypodense	O
lesions	O
related	O
to	O
the	O
proximal	O
pancreas,	O
incompletely	O
characterized.	O
Brief	O
Hospital	O
Course:	O
___	O
year-old	O
male	O
with	O
ESRD	O
on	O
HD	O
(___),	O
diastolic	O
heart	O
failure,	O
HTN,	O
known	O
history	O
of	O
bilateral	O
renal	O
masses,	O
BPH	O
who	O
presents	O
with	O
three	O
days	O
of	O
gross	O
hematuria.	O
#	O
Hematuria:	O
Patient	O
has	O
known	O
history	O
of	O
renal	O
masses	O
since	O
___	O
and	O
reports	O
being	O
followed	O
by	O
nephrologist	O
and	O
urologist	O
at	O
___.	O
He	O
has	O
declined	O
any	O
invasive	O
procedures	O
to	O
determine	O
the	O
identity	O
of	O
these	O
masses	O
in	O
the	O
past.	O
Initially	O
presented	O
to	O
OSH,	O
where	O
CT	O
abdomen/pelvis	O
demonstrated	O
known	O
masses	O
with	O
unclear	O
interval	O
change.	O
Patient	O
aware	O
of	O
the	O
possibility	O
of	O
malignancy	O
(renal,	O
bladder,	O
prostate)	O
as	O
the	O
etiology	O
for	O
his	O
hematuria	O
but	O
declined	O
invasive	O
testing	O
during	O
this	O
hospitalization.	O
OSH	O
CT	O
also	O
demonstrated	O
distended	O
bladder	O
with	O
clots	O
and	O
urology	O
was	O
consulted,	O
who	O
placed	O
three	O
way	O
foley	O
for	O
continuous	O
bladder	O
irrigation.	O
Urine	O
analysis	O
equivocal	O
but	O
culture	O
without	O
growth.	O
Patient's	O
hematocrit	O
remained	O
stable	O
and	O
patient	O
was	O
hemodynamically	O
stable	O
as	O
well.	O
Aspirin	O
was	O
held	O
during	O
episode	O
of	O
hematuria,	O
but	O
restarted	O
after	O
improvement	O
of	O
hematuria.	O
Per	O
urology	O
recommendation	O
patient	O
was	O
discharged	O
with	O
a	O
foley	O
in	O
place,	O
which	O
he	O
should	O
keep	O
in	O
for	O
5	O
days	O
until	O
he	O
sees	O
his	O
urologist.	O
There	O
was	O
no	O
gross	O
hematuria	O
on	O
CBI	O
clamping	O
trial.	O
Urology	O
did	O
not	O
recommend	O
any	O
further	O
procedure	O
and	O
recommended	O
that	O
patient	O
follow	O
up	O
with	O
his	O
outpatient	O
urologist,	O
Dr.	O
___,	O
___	O
further	O
evaluation	O
of	O
gross	O
hematuria.	O
#	O
ESRD:	O
Patient	O
has	O
had	O
ESRD	O
on	O
hemodialysis	O
(MWF)	O
since	O
___	O
most	O
likely	O
secondary	O
to	O
chronic	O
HTN	O
and	O
renal	O
masses.	O
He	O
is	O
followed	O
at	O
___	O
at	O
___	O
by	O
nephrologist,	O
Dr.	O
___.	O
On	O
admission	O
patient	O
had	O
lower	O
extremity	O
edema	O
but	O
was	O
not	O
volume	O
overloaded.	O
Evaluated	O
by	O
renal	O
team	O
and	O
underwent	O
hemodialysis	O
treatment	O
on	O
___.	O
He	O
will	O
follow	O
his	O
regular	O
schedule	O
on	O
discharge.	O
#Anemia:	O
Hematocrit	O
stable	O
after	O
review	O
of	O
outpatient	O
___	O
records	O
from	O
___.	O
#	O
Pancreatic	O
lesion:	O
The	O
CT	O
scan	O
from	O
___	O
also	O
reported	O
presence	O
of	O
incidental	O
pancreatic	O
lesion.	O
Patient	O
will	O
see	O
PCP	O
for	O
further	O
evaluation	O
and	O
management.	O
INACTIVE	O
ISSUES:	O
#	O
HTN:	O
Hemodynamically	O
stable.	O
Continued	O
home	O
Labetalol.	O
#	O
Lower	O
extremity	O
swelling:	O
Continued	O
home	O
Lasix	O
#	O
Gout:	O
Stable.	O
Alluporinol	O
renally	O
dosed	O
to	O
150mg	O
every	O
other	O
day	O
down	O
from	O
100mg	O
everyday.	O
#	O
Hyperlipidemia:	O
Stable.	O
Continued	O
simvastatin.	O
#	O
BPH:	O
Stable,	O
but	O
prostate	O
may	O
be	O
contributing	O
to	O
hematuria.	O
Continued	O
Terazosin.	O
TRANSITIONS	O
OF	O
CARE:	O
-	O
Patient	O
will	O
follow	O
up	O
with	O
Dr.	O
___	O
outpatient	O
urologist	O
for	O
further	O
work-up	O
of	O
gross	O
hematuria.	O
He	O
will	O
also	O
follow	O
up	O
with	O
his	O
nephrologist	O
Dr.	O
___	O
management	O
of	O
bilateral	O
renal	O
masses.	O
-	O
Patient	O
will	O
also	O
follow	O
up	O
with	O
PCP	O
for	O
evaluation	O
of	O
pancreatic	O
lesions	O
seen	O
on	O
___	O
CT.	O
Medications	O
on	O
Admission:	O
Allopurinol	O
___	O
mg	O
___	O
Labetalol	O
300	O
mg	O
___	O
bid	O
Lasix	O
80	O
mg	O
___	O
Protonix	O
40	O
mg	O
___	O
Sodium	O
bicarbonate	O
650	O
mg	O
___	O
tid	O
Terazosin	O
10	O
mg	O
___	O
Metolazone	O
5	O
mg	O
___	O
Zocor	O
40	O
mg	O
___	O
Dialyvite	O
___	O
ASA	O
81	O
mg	O
___	O
(has	O
not	O
taken	O
this	O
for	O
several	O
days	O
due	O
to	O
the	O
hematuria)	O
Discharge	O
Medications:	O
1.	O
allopurinol	O
___	O
mg	O
Tablet	O
Sig:	O
1.5	O
Tablets	O
___	O
EVERY	O
OTHER	O
DAY	O
(Every	O
Other	O
Day).	O
2.	O
labetalol	O
100	O
mg	O
Tablet	O
Sig:	O
Three	O
(3)	O
Tablet	O
___	O
BID	O
(2	O
times	O
a	O
day).	O
3.	O
furosemide	O
40	O
mg	O
Tablet	O
Sig:	O
Two	O
(2)	O
Tablet	O
___.	O
4.	O
terazosin	O
5	O
mg	O
Capsule	O
Sig:	O
Two	O
(2)	O
Capsule	O
___	O
once	O
a	O
day.	O
5.	O
simvastatin	O
40	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
___	O
(___).	O
6.	O
lansoprazole	O
30	O
mg	O
Tablet,Rapid	O
Dissolve,	O
___	O
Sig:	O
One	O
(1)	O
Tablet,Rapid	O
Dissolve,	O
___	O
___.	O
Disp:*30	O
Tablet,Rapid	O
Dissolve,	O
___	O
Refills:*2*	O
7.	O
metolazone	O
2.5	O
mg	O
Tablet	O
Sig:	O
Two	O
(2)	O
Tablet	O
___	O
(___).	O
8.	O
Dialyvite	O
Oral	O
9.	O
sodium	O
bicarbonate	O
650	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
___	O
three	O
times	O
a	O
day.	O
10.	O
aspirin	O
81	O
mg	O
Tablet,	O
Chewable	O
Sig:	O
One	O
(1)	O
Tablet,	O
Chewable	O
___.	O
Discharge	O
Disposition:	O
Home	O
Discharge	O
Diagnosis:	O
1.	O
Gross	O
Hematuria	O
2.	O
Bilateral	O
Renal	O
Masses	O
3.	O
Benign	O
Prostatic	O
hypertrophy	O
Discharge	O
Condition:	O
Mental	O
Status:	O
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Independently_mobile
-	B-Independently_mobile
Independent.	B-Independently_mobile
Discharge	O
Instructions:	O
Dear	O
Mr.	O
___,	O
it	O
was	O
a	O
pleasure	O
taking	O
care	O
of	O
you	O
at	O
___.	O
You	O
presented	O
with	O
complaints	O
of	O
blood	O
in	O
your	O
urine	O
for	O
three	O
days.	O
You	O
initially	O
had	O
a	O
CT	O
scan	O
at	O
___	O
which	O
showed	O
masses	O
in	O
your	O
kidneys	O
which	O
you	O
have	O
known	O
about	O
for	O
at	O
least	O
___	O
years.	O
The	O
CT	O
scan	O
additionally	O
showed	O
that	O
your	O
bladder	O
was	O
distended	O
with	O
blood	O
clots	O
in	O
it.	O
Urology	O
service	O
saw	O
you	O
in	O
the	O
emergency	O
department	O
and	O
placed	O
a	O
foley	O
catheter	O
with	O
continuous	O
irrigation.	O
Blood	O
clots	O
in	O
your	O
urine	O
gradually	O
improved	O
with	O
irrigation.	O
You	O
should	O
keep	O
your	O
foley	O
catheter	O
in	O
for	O
another	O
4	O
or	O
5	O
days	O
and	O
follow	O
up	O
with	O
Dr.	O
___	O
urologist.	O
.	O
At	O
your	O
request	O
no	O
invasive	O
procedures	O
or	O
further	O
diagnostic	O
tests	O
were	O
done	O
to	O
determine	O
the	O
cause	O
of	O
your	O
bloody	O
urine.	O
The	O
blood	O
in	O
your	O
urine	O
may	O
be	O
coming	O
from	O
the	O
masses	O
in	O
your	O
kidneys,	O
bladder	O
or	O
prostate.	O
Therefore	O
you	O
should	O
follow	O
up	O
with	O
your	O
outpatient	O
urologist	O
and	O
nephrologist	O
this	O
week	O
to	O
determine	O
the	O
exact	O
cause	O
of	O
blood	O
in	O
your	O
urine.	O
You	O
will	O
need	O
to	O
keep	O
your	O
foley	O
catheter	O
in	O
place	O
for	O
at	O
least	O
5	O
days.	O
.	O
As	O
you	O
know,	O
you	O
have	O
end	O
stage	O
renal	O
disease	O
and	O
have	O
been	O
on	O
dialysis	O
on	O
a	O
___	O
schedule.	O
You	O
should	O
continue	O
to	O
follow	O
your	O
regular	O
dialysis	O
schedule.	O
.	O
We	O
have	O
made	O
the	O
following	O
medication	O
changes	O
for	O
you.	O
-	O
CHANGED	O
Allopurinol	O
from	O
100mg	O
___	O
to	O
150mg	O
every	O
other	O
day	O
-	O
CHANGED	O
Protonix	O
40mg	O
___	O
to	O
Lansoprazole	O
Disintegrating	O
tablets	O
30mg	O
___	O
Followup	O
Instructions:	O
___	O

